Platten M., Bunse, L., Wick, A. Bunse, T., Le Cornet, L., Harting, I., Sahm, F., Khwab Sanghvi, K., Leng Tan, C., Poschke, I., Green, E., Justesen, S., Behrens, G.A., Michael, Breckwoldt, M.O., Freitag, A., Rother, L.-M., Schmitt, A., Schnell, O., Hense, J., Misch, M., Krex, D., Stevanovic, S., Tabatabai, G., Steinbach, J.P.,Bendszus, M., von Deimling, A., Schmitt, M., Wick, W. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature 2021 Apr;592(7854):463-468. doi: 10.1038/s41586-021-03363-z. Epub 2021 Mar 24 IF 42,778
Morath C*, Schmitt A*, Kleist C, Daniel V, Opelz G, Süsal C, Ibrahim E, Kälble F, Speer C, Nusshag C, Pego da Silva L, Sommerer C, Wang L, Ni M, Hückelhoven-Krauss A, Czock D, Merle U, Mehrabi A, Sander A, Hackbusch M, Eckert C, Waldherr R, Schnitzler P, Müller-Tidow C, Hoheisel JD, Mustafa SA, Alhamdani MSS, Bauer AS, Reiser J, Zeier M, Schmitt M, Schaier M, Terness P. Phase-I trial of donor-derived modified immune cell infusion in kidney transplantation. J Clin Invest. 2020: 130(5):2364-2376. PMID: 31990685. IF 12,282
Sauer, T., Parikh, K., Sharma, S., Omer, B., Sedloev, D.N., Chen, Q., Angenendt, L., Schliemann, C., Schmitt, M., Müller-Tidow, C., Gottschalk, S., Rooney, C.M. CD70-specific CAR T-cells have potent activity against Acute Myeloid Leukemia (AML) without HSC toxicity Blood, 2021 Mar 15; blood. 2020008221 doi: 10.1182/blood.2020008221. IF 17,543
Schubert ML, Kunz A, Schmitt A, Neuber B, Wang L, Hückelhoven-Krauss A, Langner S, Michels B, Wick A, Daniel V, Müller-Tidow C, Dreger P, Schmitt M. Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR. Cancers (Basel). 2020 Sep 30;12(10):2820. PMID: 33007926. IF 5,742
Schmitt M, Schmitt A, Wiesneth M, Hückelhoven A, Wu Z, Kuball J, Wang L, Schauwecker P, Hofmann S, Götz M, Michels B, Maccari B, Wuchter P, Eckstein V, Mertens T, Schnitzler P, Hartmut Döhner H, Ho AD, Bunjes DW, Dreger P, Schrezenmeier H, Greiner J. Peptide vaccination in the presence of adjuvants in patients after allogeneic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ responses. Theranostics 2017 Apr 10;7(6):1705-1718. IF 8,712, 12 citations
